Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 14 de 14
Filter
Add more filters










Publication year range
1.
Article in English | MEDLINE | ID: mdl-33163085

ABSTRACT

Current treatments for complex diseases have remarkable side effects that negatively impact patients' quality of life. Thus, natural compounds with fewer side effects represent a promising source for safe drugs. The genus Senecio is widely used in folk medicine due to its various pharmacological properties. In the present study, the total phenolic content of Senecio glaucus, which is grown in Saudi Arabia, was assessed using the Folin-Ciocalteau colorimetric method. Scavenging DPPH and ABTS assays were utilized to determine the antioxidant properties of S. glaucus fractions, and MTT assay was used to screen the cytotoxic activity of S. glaucus against various cancer cells. In addition, HPLC-UV was utilized to detect the presence of two phenolic acids, namely, vanillic acid (VA) and gallic acid (GA). Among all fractions tested, S. glaucus chloroform fraction (SGCF) yielded the highest value (125.3 mg·GA/g) in terms of total phenolic content. SGCF also exhibited the highest scavenging activities (76.7 and 74.1%) on both DPPH and ABTS assays, respectively. Similarly, SGCF also possessed the most potent cytotoxic activity against the MCF-7 cell line, with an IC50 value of 41.8 µg/ml. The validated HPLC method confirmed the presence of VA (4.8 µg/mg DW) and GA (3.9 µg/mg DW) in SGCF. Overall, our data show that S. glaucus had antioxidant and cytotoxic properties. A developed validated HPLC method which could be helpful for quantifying phenolic compounds in S. glaucus was established.

2.
Molecules ; 25(18)2020 Sep 11.
Article in English | MEDLINE | ID: mdl-32932909

ABSTRACT

Cichorium intybus L., (chicory) is employed in various traditional medicines to treat a wide range of diseases and disorders. In the current investigation, two new naphthalane derivatives viz., cichorins D (1) and E (2), along with one new anthraquinone cichorin F (3), were isolated from Cichorium intybus. In addition, three previously reported compounds viz., ß-sitosterol (4), ß-sitosterol ß-glucopyranoside (5), and stigmasterol (6) were also isolated from Cichorium intybus. Their structures were established via extensive spectroscopic data, including 1D (1H and 13C) and 2D NMR (COSY, HSQC and HMBC), and ESIMS. Cichorin E (2) has a weak cytotoxic effect on breast cancer cells (MDA-MB-468: IC50: 85.9 µM) and Ewing's sarcoma cells (SK-N-MC: IC50: 71.1 µM); cichorin F (3) also illustrated weak cytotoxic effects on breast cancer cells (MDA-MB-468: IC50: 41.0 µM and MDA-MB-231: IC50: 45.6 µM), and SK-N-MC cells (IC50: 71.9 µM). Moreover compounds 1-3 did not show any promising anthelmintic effects.


Subject(s)
Anthraquinones/pharmacology , Cichorium intybus/chemistry , Plant Extracts/chemistry , Sterols/pharmacology , Anthelmintics , Anthraquinones/isolation & purification , Cell Line, Tumor , Cell Survival/drug effects , Humans , Inhibitory Concentration 50 , Magnetic Resonance Spectroscopy , Medicine, Traditional , Molecular Structure , Naphthalenes/chemistry , Sterols/isolation & purification
4.
Genet Med ; 18(7): 686-95, 2016 07.
Article in English | MEDLINE | ID: mdl-26633546

ABSTRACT

PURPOSE: Dysmorphology syndromes are among the most common referrals to clinical genetics specialists. Inability to match the dysmorphology pattern to a known syndrome can pose a major diagnostic challenge. With an aim to accelerate the establishment of new syndromes and their genetic etiology, we describe our experience with multiplex consanguineous families that appeared to represent novel autosomal recessive dysmorphology syndromes at the time of evaluation. METHODS: Combined autozygome/exome analysis of multiplex consanguineous families with apparently novel dysmorphology syndromes. RESULTS: Consistent with the apparent novelty of the phenotypes, our analysis revealed a strong candidate variant in genes that were novel at the time of the analysis in the majority of cases, and 10 of these genes are published here for the first time as novel candidates (CDK9, NEK9, ZNF668, TTC28, MBL2, CADPS, CACNA1H, HYAL2, CTU2, and C3ORF17). A significant minority of the phenotypes (6/31, 19%), however, were caused by genes known to cause Mendelian phenotypes, thus expanding the phenotypic spectrum of the diseases linked to these genes. The conspicuous inheritance pattern and the highly specific phenotypes appear to have contributed to the high yield (90%) of plausible molecular diagnoses in our study cohort. CONCLUSION: Reporting detailed clinical and genomic analysis of a large series of apparently novel dysmorphology syndromes will likely lead to a trend to accelerate the establishment of novel syndromes and their underlying genes through open exchange of data for the benefit of patients, their families, health-care providers, and the research community.Genet Med 18 7, 686-695.


Subject(s)
Abnormalities, Multiple/diagnosis , Exome/genetics , Genomics , Hypoglycemia/diagnosis , Microcephaly/diagnosis , Abnormalities, Multiple/genetics , Abnormalities, Multiple/physiopathology , Consanguinity , Disorders of Sex Development/diagnosis , Disorders of Sex Development/genetics , Disorders of Sex Development/physiopathology , Female , High-Throughput Nucleotide Sequencing , Humans , Hypoglycemia/genetics , Hypoglycemia/physiopathology , Male , Microcephaly/genetics , Microcephaly/physiopathology , Mutation , Pedigree , Phenotype , Sequence Analysis, DNA/methods
5.
Genet Med ; 18(6): 554-62, 2016 06.
Article in English | MEDLINE | ID: mdl-26355662

ABSTRACT

PURPOSE: Retinal dystrophies (RD) are heterogeneous hereditary disorders of the retina that are usually progressive in nature. The aim of this study was to clinically and molecularly characterize a large cohort of RD patients. METHODS: We have developed a next-generation sequencing assay that allows known RD genes to be sequenced simultaneously. We also performed mapping studies and exome sequencing on familial and on syndromic RD patients who tested negative on the panel. RESULTS: Our panel identified the likely causal mutation in >60% of the 292 RD families tested. Mapping studies on all 162 familial RD patients who tested negative on the panel identified two novel disease loci on Chr2:25,550,180-28,794,007 and Chr16:59,225,000-72,511,000. Whole-exome sequencing revealed the likely candidate as AGBL5 and CDH16, respectively. We also performed exome sequencing on negative syndromic RD cases and identified a novel homozygous truncating mutation in GNS in a family with the novel combination of mucopolysaccharidosis and RD. Moreover, we identified a homozygous truncating mutation in DNAJC17 in a family with an apparently novel syndrome of retinitis pigmentosa and hypogammaglobulinemia. CONCLUSION: Our study expands the clinical and allelic spectrum of known RD genes, and reveals AGBL5, CDH16, and DNAJC17 as novel disease candidates.Genet Med 18 6, 554-562.


Subject(s)
Cadherins/genetics , Carboxypeptidases/genetics , Mitochondrial Membrane Transport Proteins/genetics , Retinal Dystrophies/genetics , Female , Homozygote , Humans , Male , Mutation , Pedigree , Phenotype , Retina/pathology , Retinal Dystrophies/diagnosis , Retinal Dystrophies/pathology , Exome Sequencing
6.
Nat Cell Biol ; 17(8): 1074-1087, 2015 Aug.
Article in English | MEDLINE | ID: mdl-26167768

ABSTRACT

Defects in primary cilium biogenesis underlie the ciliopathies, a growing group of genetic disorders. We describe a whole-genome siRNA-based reverse genetics screen for defects in biogenesis and/or maintenance of the primary cilium, obtaining a global resource. We identify 112 candidate ciliogenesis and ciliopathy genes, including 44 components of the ubiquitin-proteasome system, 12 G-protein-coupled receptors, and 3 pre-mRNA processing factors (PRPF6, PRPF8 and PRPF31) mutated in autosomal dominant retinitis pigmentosa. The PRPFs localize to the connecting cilium, and PRPF8- and PRPF31-mutated cells have ciliary defects. Combining the screen with exome sequencing data identified recessive mutations in PIBF1, also known as CEP90, and C21orf2, also known as LRRC76, as causes of the ciliopathies Joubert and Jeune syndromes. Biochemical approaches place C21orf2 within key ciliopathy-associated protein modules, offering an explanation for the skeletal and retinal involvement observed in individuals with C21orf2 variants. Our global, unbiased approaches provide insights into ciliogenesis complexity and identify roles for unanticipated pathways in human genetic disease.


Subject(s)
Cilia/genetics , Ciliary Motility Disorders/genetics , Genetic Markers , Genetic Testing/methods , Genomics/methods , Photoreceptor Cells , RNA Interference , Abnormalities, Multiple , Animals , Caenorhabditis elegans/genetics , Caenorhabditis elegans/metabolism , Caenorhabditis elegans/ultrastructure , Cerebellar Diseases/genetics , Cerebellum/abnormalities , Cilia/metabolism , Cilia/pathology , Ciliary Motility Disorders/metabolism , Ciliary Motility Disorders/pathology , Cytoskeletal Proteins , Databases, Genetic , Ellis-Van Creveld Syndrome/genetics , Eye Abnormalities/genetics , Genetic Predisposition to Disease , Genome-Wide Association Study , HEK293 Cells , High-Throughput Nucleotide Sequencing , Humans , Kidney Diseases, Cystic/genetics , Membrane Proteins/deficiency , Membrane Proteins/genetics , Mice, Inbred C57BL , Mice, Knockout , Mutation , Phenotype , Photoreceptor Cells/metabolism , Photoreceptor Cells/ultrastructure , Pregnancy Proteins/genetics , Pregnancy Proteins/metabolism , Proteins/genetics , Proteins/metabolism , Reproducibility of Results , Retina/abnormalities , Suppressor Factors, Immunologic/genetics , Suppressor Factors, Immunologic/metabolism , Transfection , Zebrafish/genetics , Zebrafish/metabolism
7.
Cell Rep ; 10(2): 148-61, 2015 Jan 13.
Article in English | MEDLINE | ID: mdl-25558065

ABSTRACT

Our knowledge of disease genes in neurological disorders is incomplete. With the aim of closing this gap, we performed whole-exome sequencing on 143 multiplex consanguineous families in whom known disease genes had been excluded by autozygosity mapping and candidate gene analysis. This prescreening step led to the identification of 69 recessive genes not previously associated with disease, of which 33 are here described (SPDL1, TUBA3E, INO80, NID1, TSEN15, DMBX1, CLHC1, C12orf4, WDR93, ST7, MATN4, SEC24D, PCDHB4, PTPN23, TAF6, TBCK, FAM177A1, KIAA1109, MTSS1L, XIRP1, KCTD3, CHAF1B, ARV1, ISCA2, PTRH2, GEMIN4, MYOCD, PDPR, DPH1, NUP107, TMEM92, EPB41L4A, and FAM120AOS). We also encountered instances in which the phenotype departed significantly from the established clinical presentation of a known disease gene. Overall, a likely causal mutation was identified in >73% of our cases. This study contributes to the global effort toward a full compendium of disease genes affecting brain function.


Subject(s)
Central Nervous System Diseases/genetics , Genetic Association Studies , Central Nervous System Diseases/pathology , Chromosome Mapping , Female , High-Throughput Nucleotide Sequencing , Homozygote , Humans , Male , Pedigree , Phenotype , Polymorphism, Single Nucleotide , Sequence Analysis, DNA
8.
Genet Med ; 17(9): 719-25, 2015 Sep.
Article in English | MEDLINE | ID: mdl-25503496

ABSTRACT

PURPOSE: Molecular karyotyping has rapidly become the test of choice in patients with neurocognitive phenotypes, but studies of its clinical utility have largely been limited to outbred populations. In consanguineous populations, single-gene recessive causes of neurocognitive phenotypes are expected to account for a relatively high percentage of cases, thus diminishing the yield of molecular karyotyping. The aim of this study was to test the clinical yield of molecular karyotyping in the highly consanguineous population of Saudi Arabia. METHODS: We have reviewed the data of 584 patients with neurocognitive phenotypes (mainly referred from pediatric neurology clinics), all evaluated by a single clinical geneticist. RESULTS: At least 21% of tested cases had chromosomal aberrations that are likely disease-causing. These changes include both known and novel deletion syndromes. The higher yield of molecular karyotyping in this study as compared with the commonly cited 11% can be explained by our ability to efficiently identify single-gene disorders, thus enriching the samples that underwent molecular karyotyping for de novo chromosomal aberrations. We show that we were able to identify a causal mutation in 37% of cases on a clinical basis with the help of autozygome analysis, thus bypassing the need for molecular karyotyping. CONCLUSION: Our study confirms the clinical utility of molecular karyotyping even in highly consanguineous populations.


Subject(s)
Chromosome Disorders/genetics , Consanguinity , Neurocognitive Disorders/genetics , Adolescent , Adult , Child , Chromosome Aberrations , Chromosome Disorders/diagnosis , Chromosome Disorders/epidemiology , DNA Copy Number Variations , Developmental Disabilities , Female , Genetic Association Studies , Humans , Intellectual Disability/genetics , Karyotyping/methods , Male , Neurocognitive Disorders/diagnosis , Neurocognitive Disorders/epidemiology , Phenotype , Polymorphism, Single Nucleotide , Retrospective Studies , Saudi Arabia/epidemiology , Young Adult
9.
PLoS Genet ; 9(12): e1004030, 2013.
Article in English | MEDLINE | ID: mdl-24367280

ABSTRACT

The use of autozygosity as a mapping tool in the search for autosomal recessive disease genes is well established. We hypothesized that autozygosity not only unmasks the recessiveness of disease causing variants, but can also reveal natural knockouts of genes with less obvious phenotypic consequences. To test this hypothesis, we exome sequenced 77 well phenotyped individuals born to first cousin parents in search of genes that are biallelically inactivated. Using a very conservative estimate, we show that each of these individuals carries biallelic inactivation of 22.8 genes on average. For many of the 169 genes that appear to be biallelically inactivated, available data support involvement in modulating metabolism, immunity, perception, external appearance and other phenotypic aspects, and appear therefore to contribute to human phenotypic variation. Other genes with biallelic inactivation may contribute in yet unknown mechanisms or may be on their way to conversion into pseudogenes due to true recent dispensability. We conclude that sequencing the autozygome is an efficient way to map the contribution of genes to human phenotypic variation that goes beyond the classical definition of disease.


Subject(s)
Consanguinity , Exome/genetics , Genes, Recessive/genetics , Phenotype , Gene Knockout Techniques , Gene Silencing , High-Throughput Nucleotide Sequencing , Homozygote , Humans , Mutation , Polymorphism, Single Nucleotide
10.
J Clin Immunol ; 33(8): 1403-6, 2013 Nov.
Article in English | MEDLINE | ID: mdl-24105461

ABSTRACT

PURPOSE: Patients with autosomal recessive cyclic neutropenia have no known causative genetic defect yet. METHODS: Autozygosity mapping on two branches of an extended multiplex consanguineous family presenting with cyclic neutropenia or severe congenital neutropenia to look for candidate gene, followed by candidate gene selection and sequencing. RESULTS: A single autozygous interval on Chr17:33,901,938-45,675,414 that is exclusively shared by the affected members was identified. This interval spans 11.8 Mb and contains 30 genes. Review of these genes highlighted G6PC3 as the most likely candidate given its known role in neutrophil biology. Direct sequencing revealed a novel homozygous mutation (NM_138387.3, c.974T > G, p.Leu325Arg). Two of our patients had associated congenital defects that are known to occur in patients with G6PC3 mutations, including congenital heart disease and intermittent thrombocytopenia. CONCLUSION: Biallelic G6PC3 defects should be considered in patients with autosomal recessive cyclic neutropenia, especially those with typical associated congenital defects.


Subject(s)
Glucose-6-Phosphatase/genetics , Homozygote , Mutation , Neutropenia/diagnosis , Neutropenia/genetics , Severity of Illness Index , Child , Genes, Recessive , Humans , Male , Neutropenia/immunology , Pedigree , Phenotype
11.
Am J Hum Genet ; 93(2): 313-20, 2013 Aug 08.
Article in English | MEDLINE | ID: mdl-23830514

ABSTRACT

Myopia is an extremely common eye disorder but the pathogenesis of its isolated form, which accounts for the overwhelming majority of cases, remains poorly understood. There is strong evidence for genetic predisposition to myopia, but determining myopia genetic risk factors has been difficult to achieve. We have identified Mendelian forms of myopia in four consanguineous families and implemented exome/autozygome analysis to identify homozygous truncating variants in LRPAP1 and CTSH as the likely causal mutations. LRPAP1 encodes a chaperone of LRP1, which is known to influence TGF-ß activity. Interestingly, we observed marked deficiency of LRP1 and upregulation of TGF-ß in cells from affected individuals, the latter being consistent with available data on the role of TGF-ß in the remodeling of the sclera in myopia and the high frequency of myopia in individuals with Marfan syndrome who characteristically have upregulation of TGF-ß signaling. CTSH, on the other hand, encodes a protease and we show that deficiency of the murine ortholog results in markedly abnormal globes consistent with the observed human phenotype. Our data highlight a role for LRPAP1 and CTSH in myopia genetics and demonstrate the power of Mendelian forms in illuminating new molecular mechanisms that may be relevant to common phenotypes.


Subject(s)
Cathepsin H/genetics , LDL-Receptor Related Protein-Associated Protein/genetics , Low Density Lipoprotein Receptor-Related Protein-1/genetics , Marfan Syndrome/genetics , Mutation , Myopia/genetics , Transforming Growth Factor beta/genetics , Adolescent , Animals , Cathepsin H/metabolism , Child , Child, Preschool , Female , Gene Expression , Genetic Predisposition to Disease , Homozygote , Humans , Infant , LDL-Receptor Related Protein-Associated Protein/metabolism , Low Density Lipoprotein Receptor-Related Protein-1/metabolism , Male , Marfan Syndrome/metabolism , Marfan Syndrome/pathology , Mice , Myopia/metabolism , Myopia/pathology , Pedigree , Phenotype , Sclera/metabolism , Sclera/pathology , Severity of Illness Index , Transforming Growth Factor beta/metabolism
12.
J Inherit Metab Dis ; 36(6): 997-1004, 2013 Nov.
Article in English | MEDLINE | ID: mdl-23315216

ABSTRACT

PURPOSE: Transaldolase deficiency is a recently described inborn error of pentose phosphate pathway. We conducted this study to further delineate the associated phenotype. METHODS AND RESULTS: We report on 12 new cases representing six families with this metabolic defect that were observed over an 8 year span. None of these cases received the correct diagnosis initially because of significant overlap in the presenting symptoms (growth retardation, dysmorphic features, cutis laxa, congenital heart disease, hepatosplenomegaly, pancytopenia, and bleeding tendency) with a wide range of genetic disorders. However, the consanguineous nature of these families allowed us to pursue autozygome analysis, which highlighted TALDO as the likely candidate gene and sequencing confirmed segregation of a novel homozygous mutation with the disease in all the studied families. Biochemical analysis was also consistent with transaldolase deficiency. CONCLUSION: This study expands the clinical definition of transaldolase deficiency, and adds to its allelic heterogeneity. In addition, we emphasize the diagnostic challenge posed by this rare and pleiotropic metabolic disorder.


Subject(s)
Carbohydrate Metabolism, Inborn Errors/diagnosis , Carbohydrate Metabolism, Inborn Errors/genetics , Transaldolase/deficiency , Child , Child, Preschool , Consanguinity , Family , Fatal Outcome , Female , Genetic Heterogeneity , Humans , Infant , Infant, Newborn , Male , Pedigree , Phenotype , Transaldolase/genetics
13.
Genome Res ; 23(2): 236-47, 2013 Feb.
Article in English | MEDLINE | ID: mdl-23105016

ABSTRACT

Retinal dystrophy (RD) is a heterogeneous group of hereditary diseases caused by loss of photoreceptor function and contributes significantly to the etiology of blindness globally but especially in the industrialized world. The extreme locus and allelic heterogeneity of these disorders poses a major diagnostic challenge and often impedes the ability to provide a molecular diagnosis that can inform counseling and gene-specific treatment strategies. In a large cohort of nearly 150 RD families, we used genomic approaches in the form of autozygome-guided mutation analysis and exome sequencing to identify the likely causative genetic lesion in the majority of cases. Additionally, our study revealed six novel candidate disease genes (C21orf2, EMC1, KIAA1549, GPR125, ACBD5, and DTHD1), two of which (ACBD5 and DTHD1) were observed in the context of syndromic forms of RD that are described for the first time.


Subject(s)
Exome , Mutation , Retinal Dystrophies/genetics , Family , Genetic Association Studies , Genotype , Humans , Phenotype , Sequence Analysis, DNA
14.
Eur J Hum Genet ; 20(4): 420-7, 2012 Apr.
Article in English | MEDLINE | ID: mdl-22353939

ABSTRACT

Bardet-Biedl syndrome (BBS) is a model disease for ciliopathy in humans. The remarkable genetic heterogeneity that characterizes this disease is consistent with accumulating data on the interaction between the proteins encoded by the 14 BBS genes identified to date. Previous reports suggested that such interaction may also extend to instances of oligogenic inheritance in the form of triallelism which defies the long held view of BBS as an autosomal recessive disease. In order to investigate the magnitude of triallelism in BBS, we conducted a comprehensive analysis of all 14 BBS genes as well as the CCDC28B-modifier gene in a cohort of 29 BBS families, most of which are multiplex. Two in trans mutations in a BBS gene were identified in each of these families for a total of 20 mutations including 12 that are novel. In no instance did we observe two mutations in unaffected members of a given family, or observe the presence of a third allele that convincingly acted as a modifier of penetrance and supported the triallelic model of BBS. In addition to presenting a comprehensive genotype/phenotype overview of a large set of BBS mutations, including the occurrence of nonsyndromic retinitis pigmentosa in a family with a novel BBS9 mutation, our study argues in favor of straightforward autosomal recessive BBS in most cases.


Subject(s)
Alleles , Bardet-Biedl Syndrome/genetics , Cell Cycle Proteins/genetics , Cohort Studies , Cytoskeletal Proteins , Family , Genes, Modifier , Humans , Male
SELECTION OF CITATIONS
SEARCH DETAIL
...